Cargando…

Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease

OBJECTIVES: Left atrial appendage occlusion (LAAO) in non-valvar atrial fibrillation (AF) reduces cardioembolic strokes. Despite increased risk, trials exclude valvar AF in structural heart diseases where clots extend beyond appendage. METHODS: Patients with AF and relative risks for oral anticoagul...

Descripción completa

Detalles Bibliográficos
Autores principales: Raghuram, Palaparti, Pavithran, Sreeja, Sivakumar, Kothandam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670275/
https://www.ncbi.nlm.nih.gov/pubmed/33189196
http://dx.doi.org/10.1016/j.ihj.2020.07.019
_version_ 1783610708353613824
author Raghuram, Palaparti
Pavithran, Sreeja
Sivakumar, Kothandam
author_facet Raghuram, Palaparti
Pavithran, Sreeja
Sivakumar, Kothandam
author_sort Raghuram, Palaparti
collection PubMed
description OBJECTIVES: Left atrial appendage occlusion (LAAO) in non-valvar atrial fibrillation (AF) reduces cardioembolic strokes. Despite increased risk, trials exclude valvar AF in structural heart diseases where clots extend beyond appendage. METHODS: Patients with AF and relative risks for oral anticoagulation (OAC) needing structural interventions underwent concomitant LAAO. After six months of OAC, aspirin was continued. Transesophageal echocardiogram was done three monthly till one year and yearly thereafter. The patient demographics, procedural details, post-procedural follow-up were analyzed. RESULTS: Nine patients aged 51.5 ± 6.3 years with AF underwent LAAO concomitantly with balloon mitral valvotomy in four patients, atrial septal defect device closure in four and periprosthetic mitral leak closure in one patient. Six patients had heart failure, four had prior embolic events, and two had documented LAA thrombus. The mean CHADS(2)VASc score was 2.44 ± 0.8 and mean HASBLED score was 3.0 ± 0.8. Devices included Amplatzer Cardiac Plug™ in six patients, LAmbre™ Lifetech device in two and Watchman™ device in one. All procedures were successful without acute complications. A patient developed pericardial effusion at six months requiring pericardiocentesis. Early device-associated thrombus in one patient resolved after OAC for six months. No embolic events occurred on follow-up. CONCLUSION: On a detailed literature search, this largest LAAO experience in structural heart diseases indicates its utility. OAC for six months followed by aspirin seems to prevent thrombus formation in these patients. The only incidence of early thrombus formation indicates immunity from clot formation after device endothelialisation. Larger multicenter trials combining LAAO with structural interventions in valvular AF are warranted in developing nations.
format Online
Article
Text
id pubmed-7670275
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-76702752020-11-23 Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease Raghuram, Palaparti Pavithran, Sreeja Sivakumar, Kothandam Indian Heart J Original Article OBJECTIVES: Left atrial appendage occlusion (LAAO) in non-valvar atrial fibrillation (AF) reduces cardioembolic strokes. Despite increased risk, trials exclude valvar AF in structural heart diseases where clots extend beyond appendage. METHODS: Patients with AF and relative risks for oral anticoagulation (OAC) needing structural interventions underwent concomitant LAAO. After six months of OAC, aspirin was continued. Transesophageal echocardiogram was done three monthly till one year and yearly thereafter. The patient demographics, procedural details, post-procedural follow-up were analyzed. RESULTS: Nine patients aged 51.5 ± 6.3 years with AF underwent LAAO concomitantly with balloon mitral valvotomy in four patients, atrial septal defect device closure in four and periprosthetic mitral leak closure in one patient. Six patients had heart failure, four had prior embolic events, and two had documented LAA thrombus. The mean CHADS(2)VASc score was 2.44 ± 0.8 and mean HASBLED score was 3.0 ± 0.8. Devices included Amplatzer Cardiac Plug™ in six patients, LAmbre™ Lifetech device in two and Watchman™ device in one. All procedures were successful without acute complications. A patient developed pericardial effusion at six months requiring pericardiocentesis. Early device-associated thrombus in one patient resolved after OAC for six months. No embolic events occurred on follow-up. CONCLUSION: On a detailed literature search, this largest LAAO experience in structural heart diseases indicates its utility. OAC for six months followed by aspirin seems to prevent thrombus formation in these patients. The only incidence of early thrombus formation indicates immunity from clot formation after device endothelialisation. Larger multicenter trials combining LAAO with structural interventions in valvular AF are warranted in developing nations. Elsevier 2020 2020-07-28 /pmc/articles/PMC7670275/ /pubmed/33189196 http://dx.doi.org/10.1016/j.ihj.2020.07.019 Text en © 2020 Cardiological Society of India. Published by Elsevier B.V. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Raghuram, Palaparti
Pavithran, Sreeja
Sivakumar, Kothandam
Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
title Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
title_full Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
title_fullStr Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
title_full_unstemmed Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
title_short Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
title_sort unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670275/
https://www.ncbi.nlm.nih.gov/pubmed/33189196
http://dx.doi.org/10.1016/j.ihj.2020.07.019
work_keys_str_mv AT raghurampalaparti unconventionalcombinationofleftatrialappendagedeviceocclusioninpatientswithatrialfibrillationwhoneededconcomitantcatheterinterventionsforunderlyingstructuralheartdisease
AT pavithransreeja unconventionalcombinationofleftatrialappendagedeviceocclusioninpatientswithatrialfibrillationwhoneededconcomitantcatheterinterventionsforunderlyingstructuralheartdisease
AT sivakumarkothandam unconventionalcombinationofleftatrialappendagedeviceocclusioninpatientswithatrialfibrillationwhoneededconcomitantcatheterinterventionsforunderlyingstructuralheartdisease